ArticleRenal failure2026
Bioinspired hybrid optimisation and deep belief neural networks for early chronic kidney disease detection: an explainable clinical AI framework.
Article in Renal failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The early detection of chronic kidney disease (CKD) can lead to timely and appropriate clinical intervention. However, most CKD diagnostic systems rely on redundant features and provide unreliable results in small and unbalanced datasets. Therefore, it is challenging to apply them in clinical settings due to a lack of transparency, as well as the extensive amount of time and effort to fine-tune them using manual labor. This article outlines an algorithm to test CKD automatically with a hybrid spiral search strategy-based binary gravitational search algorithm (SSS-BGSA) with elephant herding optimization (EHO) to optimize a Deep Belief Neural Network (DBNN). The code pipeline was designed to involve automated feature selection and model parameter optimization. The objective of using SSS-BGSA in the study was to enhance the exploration-exploitation tradeoff of the original BGSA by a non-linear spiral search pattern. Training of the DBNN using the selected features and optimization of the DBNN parameters were also done using EHO to enhance convergence rate and learning efficiency. The framework was evaluated on the UCI CKD dataset (25 attributes) using nested stratified 5-fold cross-validation. The suggested SSS-BGSA-EHO-DBNN demonstrated a competitive performance (Accuracy = 0.973 ± 0.022, AUC =0.996 ± 0.006), as well as identifying a minimum of 7 clinically important features. Specific gravity, hypertension, packed cell volume, glucosuria, and blood urea were identified as the most important features. The proposed SSS-BGSA-EHO-DBNN framework demonstrates that dual-stage optimization combined with explainable deep learning can yield a fully automated, interpretable, and computationally efficient CKD screening pipeline.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.